FeesSafety
Pluang+

Filtronic strengthens role in SpaceX's Starlink with GaN amplifiers and equity warrants, boosting growth outlook.

Market News
29 May 2026
Seeking Alpha
View Source
Bullish
Filtronic strengthens role in SpaceX's Starlink with GaN amplifiers and equity warrants, boosting growth outlook.

Filtronic Plc is a key supplier of GaN-based RF amplifiers for SpaceX's Starlink satellite network, playing a crucial role in next-generation satellite communications. The company's strategic partnership with SpaceX includes equity warrants, signaling strong confidence in Filtronic's growth potential and expanding its involvement beyond a traditional supplier role. Despite risks from heavy customer concentration and Elon Musk's cost discipline, Filtronic's high margins, pricing power, and leading profitability support a premium valuation. The company is actively diversifying its revenue into aerospace and defense sectors and maintains a strong balance sheet, which bolsters optimism amid high volatility and execution risks.

More News

Tango funds mobile cancer screening in Ukraine, aiding early detection and medical training.

Tango funds mobile cancer screening in Ukraine, aiding early detection and medical training.

Tango, a global live-streaming platform, has donated tens of thousands of dollars to support FRIDA Ukraine's mobile cancer screening program. This initiative brings essential cancer detection and preventive healthcare services directly to underserved...

Others
Neutral
46 minutes ago
California's 2027 AI safety rules clash with Pentagon cyber directives, pushing veteran-led tech defense innovation.

California's 2027 AI safety rules clash with Pentagon cyber directives, pushing veteran-led tech defense innovation.

California's upcoming AI safety mandate, effective May 15, 2027, is creating tension with federal military cybersecurity rules under the Defense Federal Acquisition Regulation Supplement (DFARS). Veteran-led engineering groups have developed advanced...

Market News
Neutral
50 minutes ago
Each 1% profit margin gain at BNSF adds $230M cash flow to Berkshire Hathaway, says Greg Abel.

Each 1% profit margin gain at BNSF adds $230M cash flow to Berkshire Hathaway, says Greg Abel.

Greg Abel highlighted that every one-point increase in BNSF's profit margin translates to about $230 million in additional cash flow for Berkshire Hathaway. This underscores the significant impact BNSF's operational efficiency has on Berkshire's over...

Market News
Bullish
1 hour ago
Petosemtamab shows strong response rates in metastatic colorectal cancer Phase 2 trial, supporting ongoing Phase 3 studies.

Petosemtamab shows strong response rates in metastatic colorectal cancer Phase 2 trial, supporting ongoing Phase 3 studies.

Genmab announced updated Phase 2 trial results for petosemtamab, an investigational antibody, showing objective response rates of 75% in first-line and 67% in second-line metastatic colorectal cancer patients. The drug demonstrated promising durabili...

Company Fundamentals
Bullish
4 hours ago
NovaBridge's givastomig shows strong Phase 1b results, advancing towards Phase 3 for gastric cancer treatment

NovaBridge's givastomig shows strong Phase 1b results, advancing towards Phase 3 for gastric cancer treatment

NovaBridge Biosciences announced updated Phase 1b data for givastomig, a bispecific antibody for first-line metastatic gastroesophageal adenocarcinoma, showing durable clinical benefits with an 8 mg/kg dose selected for further development. The data,...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App